Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

1,053 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,053 results

Large-scale testing (Phase 3)Ended earlyNCT00662688
What this trial is testing

Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityPancreatic CancerThromboembolism
GERCOR - Multidisciplinary Oncology Cooperative Group 42
Testing effectiveness (Phase 2)WithdrawnNCT03778879
What this trial is testing

Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B

Who this might be right for
Adenocarcinoma of the PancreasPancreas Cancer
Alan Katz
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05562297
What this trial is testing

Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIB+1 more
Shanghai Zhongshan Hospital 50
Not applicableStudy completedNCT03834701
What this trial is testing

Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms

Who this might be right for
Neuroendocrine TumorsNeuroendocrine CarcinomaPancreas Neoplasm+1 more
Catholic University of the Sacred Heart 60
Early research (Phase 1)Looking for participantsNCT06867497
What this trial is testing

Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Boryung Pharmaceutical Co., Ltd 20
Not applicableUnknownNCT03570502
What this trial is testing

Incidence of POPF in the Resection of the Left Pancreas With RFAT

Who this might be right for
Pancreas NeoplasmPancreas CancerPancreatic Adenocarcinoma+1 more
Hospital del Mar 38
Testing effectiveness (Phase 2)Study completedNCT00094445
What this trial is testing

Trial of Curcumin in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
M.D. Anderson Cancer Center 50
Large-scale testing (Phase 3)Study completedNCT00099294
What this trial is testing

Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Threshold Pharmaceuticals 300
Large-scale testing (Phase 3)Looking for participantsNCT07409272
What this trial is testing

Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 614
Testing effectiveness (Phase 2)Study completedNCT00112528
What this trial is testing

Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Alliance for Clinical Trials in Oncology 53
Not applicableApproved For MarketingNCT04100694
What this trial is testing

Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor

Who this might be right for
NRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more
Merus B.V.
Not applicableStudy completedNCT06336694
What this trial is testing

A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
First Affiliated Hospital, Sun Yat-Sen University 302
Not applicableStudy completedNCT03266757
What this trial is testing

Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Hellenic Society of Medical Oncology 200
Testing effectiveness (Phase 2)Study completedNCT01465659
What this trial is testing

Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Alpha Cell CarcinomaPancreatic Beta Islet Cell CarcinomaPancreatic Delta Cell Carcinoma+2 more
Northwestern University 29
Early research (Phase 1)UnknownNCT06081322
What this trial is testing

Evaluate the Safety and Efficacy of PRRT With 177Lu-EB-FAPI in Patients With Advanced Cholopancreatic Tumors

Who this might be right for
Advanced Pancreatic Cancer and Cholangiocarcinoma
Zhejiang University 29
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Very early researchUnknownNCT02929797
What this trial is testing

Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 72
Testing effectiveness (Phase 2)Study completedNCT00203892
What this trial is testing

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Chicago 23
Large-scale testing (Phase 3)Looking for participantsNCT06897644
What this trial is testing

Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Adenocarcinoma Advanced or Metastatic
Gruppo Oncologico del Nord-Ovest 340
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+7 more
Udai Kammula 20
Load More Results